<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Immunity and Infection</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F1979EE4-A9E3-4657-94AD-BB70CDEBBD15"><gtr:id>F1979EE4-A9E3-4657-94AD-BB70CDEBBD15</gtr:id><gtr:firstName>Lucy</gtr:firstName><gtr:surname>Walker</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G120%2F854"><gtr:id>A0ABBC28-E5BA-4C71-94FF-4E7CE6387950</gtr:id><gtr:title>Generation and Function of Antigen-specific Regulatory T cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G120/854</gtr:grantReference><gtr:abstractText>The immune system is a powerful weapon, and the diseases that ensue when it attacks part of our own body (autoimmunity), rather than fighting infections, can be devastating. One example is diabetes in which the immune system attacks the pancreas. Recently, scientists have identified a new group of white blood cells (termed regulatory T cells) which have the specific task of preventing autoimmunity in normal individuals. We know that in mice, eliminating these cells is sufficient to trigger multiple autoimmune diseases. This raises the possibility that people develop autoimmune diseases because they somehow fail to produce enough regulatory T cells, or because the ones they do make cannot function properly. If indeed this is the case, we could potentially treat autoimmune diseases by injecting people with regulatory T cells, or with treatments to stimulate their production. My research exploits a novel mouse model which allows us to dissect how the generation and function of regulatory T cells is controlled. This information will potentially help us to design strategies to modulate regulatory T cells in individuals with autoimmunity with the aim of controlling their disease.</gtr:abstractText><gtr:technicalSummary>The reason why the immune system attacks self tissues in certain individuals leading to autoimmune disease is still not known. This does not seem to simply reflect a failure to delete self-reactive T cells during thymic development, since T cells which recognize self-proteins are also present in healthy individuals. An increasingly likely alternative is that disease results from defects in the peripheral tolerance mechanisms that normally control self-reactive T cells in healthy individuals. A major aspect of peripheral tolerance is the role played by a specialized subset of lymphocytes termed regulatory T cells (Treg). As a consequence of the overwhelming evidence indicating the importance of this population, Treg are now a recognized component of cellular immunity. To explore the function of Treg in a defined way I have developed an experimental system for the production of Treg whose specificity is directed by a transgenic T cell receptor (TCR). Since these cells can be stimulated with a known antigen and tracked with a clonotypic antibody, they can be used to tackle questions that have previously not been possible to address. For the first time, the antigen-responsiveness of Treg can be addressed under physiological conditions, using the clonotypic antibody to track the transgenic Treg. Furthermore, I have also developed systems to study how these Treg inhibit inflammation induced by pathogenic CD4 cells specific for the same antigen. This system therefore represents a significant step forward from crude analysis of polyclonal CD25+ populations and instead allows analysis of a defined cohort of Treg as they respond to their specific antigen. The aim of this proposal is to use this novel transgenic model to advance our understanding of how Treg develop in response to endogenous antigens and to unravel the mechanisms by which they inhibit organ-specific autoimmunity.</gtr:technicalSummary><gtr:fund><gtr:end>2008-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>685436</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Immune Regulation</gtr:department><gtr:description>MRC Centre Collaboration</gtr:description><gtr:id>0A3F5F67-009F-4F0E-AF4E-81D19893FE47</gtr:id><gtr:impact>All of the publications produced by my group have been supported by the infrastructure of the MRC Centre for Immune Regulation. This reflects not just support for facilities (eg cell sorting) but also interaction and scientific discussion between colleagues within the Centre.</gtr:impact><gtr:outcomeId>BH3yFAMx4s3-1</gtr:outcomeId><gtr:partnerContribution>Provision of PhD studentships and of research infrastructure support for my group.</gtr:partnerContribution><gtr:piContribution>My research team has both contributed to and benefited from interactions with colleagues within the MRC Centre for Immune Regulation.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited speaker at EuroSciCon meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>59C6A1DE-4494-4ED1-9352-BC5ED34F86B5</gtr:id><gtr:impact>Invited speaker at Euroscicon meeting entitled &amp;quot;Analysing the Phenotype and Function of Regulatory T cells&amp;quot;. I presented data generated during my Career Development Award for discussion.

Useful discussion.</gtr:impact><gtr:outcomeId>113B7BCC6B3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at Imperial College London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2A49029F-259E-47F3-ADF1-FE955A1D23AF</gtr:id><gtr:impact>Invited speaker for John Humphrey Lecture series. I presented data generated during my Career Development Award for discussion.

Useful discussion.</gtr:impact><gtr:outcomeId>915B2669D9B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Event for World Diabetes Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E9064A83-B7FB-42CA-91FC-A4A0146868C3</gtr:id><gtr:impact>World Diabetes Day (14th November) is commemorated by the world-wide lighting of landmark buildings in blue (the colour of the international diabetes symbol). I organised for Birmingham University's historic clock tower, Old Joe, to be illuminated blue for the evening. The aim of the exercise was to raise awareness of diabetes, in order to encourage screening of at-risk individuals, and also to highlight the research performed by myself and my colleagues at Birmingham University. The event was advertised on the University website in addition to the websites of the Juvenille Diabetes Research Foundation (JDRF) and International Diabetes Federation (IDF). The MRC press office were also notified. A press-release was prepared containing lay summaries of the research performed as part of my MRC Career Development Award along with research performed by my colleagues. The event was attended by local press.

Useful engagement with the local community.</gtr:impact><gtr:outcomeId>0C1BA017EEF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Collaborative visit to MedImmune</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FE6B1C4F-8F15-4C96-A1A3-9138497406D7</gtr:id><gtr:impact>To foster a new collaborative link with researchers at MedImmune (Gaithesburg, MD, USA), I visited their headquarters and presented some of the findings from my Career Development Award in the form of a seminar.

Useful discussion.</gtr:impact><gtr:outcomeId>8633216574E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Collaborative visit to Wyeth Research</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3E59128C-4B08-48E5-A954-A5B3276EACB3</gtr:id><gtr:impact>To foster new collaborative links with researchers at Wyeth (Boston, MA, USA) I visited and presented some of the data generated during my Career Development Award.

Useful discussion.</gtr:impact><gtr:outcomeId>D8A492A1C0A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at King's College London School of Medicine at Guy's Hospital</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>971F50C4-5383-4875-820F-29D1A046C9D3</gtr:id><gtr:impact>Invited speaker in the Immunobiology &amp;amp; Infectious Diseases Seminar Programme at King's College London School of Medicine at Guy's Hospital. I presented data generated during my Career Development Award for discussion.

Useful discussion.</gtr:impact><gtr:outcomeId>62B788447A5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at British Society for Rheumatology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7DF625F3-75FD-4BB1-982B-F652C6D69EC4</gtr:id><gtr:impact>Invited speaker at the British Society for Rheumatology annual congress in Liverpool. I presented data generated as part of my Career Development Award for discussion.

Useful discussion.</gtr:impact><gtr:outcomeId>79CB9CAEDA0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at La Jolla Institute for Allergy and Immunology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9CBADD2E-1B36-4F3E-B844-81838FD16F9E</gtr:id><gtr:impact>Invited speaker at La Jolla Institute for Allergy and Immunology, CA, USA. I presented data generated as part of my Career Development Award for discussion.

Useful discussion.</gtr:impact><gtr:outcomeId>B87552B5EF9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at Hopital de la Pitie-Salpetriere</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>554AFA8C-D9D0-4F8B-8711-5A757773B884</gtr:id><gtr:impact>Invited speaker as part of the Immunology programme at Hopital de la Pitie-Salpetriere, Paris France. I presented data generated as part of my Career Development Award for discussion.

Useful discussion.</gtr:impact><gtr:outcomeId>AD1FA70D898</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>70500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK, PhD Studentship</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:fundingRef>08/0003762</gtr:fundingRef><gtr:id>50E8E9E4-4DBA-4210-BBFC-35996DC473D0</gtr:id><gtr:outcomeId>0244505B2DD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>304000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (How do B cells control T cell pancreas infiltration?)</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>6B253E10-E545-45AC-A623-F39F8DB8DBB9</gtr:id><gtr:outcomeId>7AA89936DEC0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Senior Non-Clinical Fellowship</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>FCCCCF07-FCAA-4313-9371-5E3FE73C8849</gtr:id><gtr:outcomeId>FD41640280C0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>445500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>JDRF Project Grant</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Juvenile Diabetes Research Foundation (JDRF)</gtr:fundingOrg><gtr:fundingRef>1-2009-355</gtr:fundingRef><gtr:id>68816A0E-82D3-4899-92A9-3EA2BB290C93</gtr:id><gtr:outcomeId>38069A2FCD60</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>39AA3302-1E74-488C-AAF5-9C19F2F29E29</gtr:id><gtr:title>Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ed0df261075a5ddb2976f16f37b0980"><gtr:id>1ed0df261075a5ddb2976f16f37b0980</gtr:id><gtr:otherNames>Clough LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>AE99B56504A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBE3CA85-2C9A-46D5-8BE9-98F7C26FDA42</gtr:id><gtr:title>Natural Treg in autoimmune diabetes: all present and correct?</gtr:title><gtr:parentPublicationTitle>Expert opinion on biological therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/806333cf634d7c3a25064d1081e95c7e"><gtr:id>806333cf634d7c3a25064d1081e95c7e</gtr:id><gtr:otherNames>Walker LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2598</gtr:issn><gtr:outcomeId>D2E67435E2A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>181C8437-B6DF-4A8D-B638-31BCA9667AD6</gtr:id><gtr:title>Regulatory T cells: Folate receptor 4: a new handle on regulation and memory?</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/806333cf634d7c3a25064d1081e95c7e"><gtr:id>806333cf634d7c3a25064d1081e95c7e</gtr:id><gtr:otherNames>Walker LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn><gtr:outcomeId>18F8F236519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6F8C0CC-A540-45EA-923C-4552600ABB3C</gtr:id><gtr:title>Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18aa4e371fa1e255116f708571ea6d0e"><gtr:id>18aa4e371fa1e255116f708571ea6d0e</gtr:id><gtr:otherNames>Patton DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>C7C64EDF2C1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13666E21-B5D5-4935-9A0F-D5883B0CC7C1</gtr:id><gtr:title>Regulatory T cells overturned: the effectors fight back.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/806333cf634d7c3a25064d1081e95c7e"><gtr:id>806333cf634d7c3a25064d1081e95c7e</gtr:id><gtr:otherNames>Walker LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>0AF4AB1A852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E66F353-F6A3-49B6-A897-5D30A807E0BF</gtr:id><gtr:title>The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a2e46885d82d9619ed85a74c89c393f"><gtr:id>9a2e46885d82d9619ed85a74c89c393f</gtr:id><gtr:otherNames>Sansom DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>B09E1617CDC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B8A1A92-71B5-4EC4-AA6D-AA32F6ED3D62</gtr:id><gtr:title>Regulating Treg cells at sites of inflammation.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8989f5865f197189888f9c1035df9835"><gtr:id>8989f5865f197189888f9c1035df9835</gtr:id><gtr:otherNames>Lazarski CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>81696E741EF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B0C5AE9-7E67-4B4C-B063-8B4BBE821C1C</gtr:id><gtr:title>Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/420f0ab7ee444dff18e8e987ac5e025a"><gtr:id>420f0ab7ee444dff18e8e987ac5e025a</gtr:id><gtr:otherNames>Schmidt EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>1970B4A272D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06673295-EC21-4D26-966E-2D2213C602F7</gtr:id><gtr:title>Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f991f5733bfdcb106e59df3e5664d189"><gtr:id>f991f5733bfdcb106e59df3e5664d189</gtr:id><gtr:otherNames>Eksteen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>401A4E8D3CA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>219763D9-AA47-4FF8-ADCA-B823E90D730A</gtr:id><gtr:title>B1 cells promote pancreas infiltration by autoreactive T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d6a1660ecca4e0289956781b74f791a"><gtr:id>4d6a1660ecca4e0289956781b74f791a</gtr:id><gtr:otherNames>Ryan GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>kvPExpsHRYh</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G120/854</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>